- Report
- July 2025
Global
From €4349EUR$4,900USD£3,777GBP
- Report
- June 2025
- 120 Pages
Global
From €4349EUR$4,900USD£3,777GBP
- Report
- June 2025
Global
From €4349EUR$4,900USD£3,777GBP
- Report
- May 2025
- 100 Pages
Global
From €4349EUR$4,900USD£3,777GBP
- Report
- May 2025
- 100 Pages
Global
From €4349EUR$4,900USD£3,777GBP
- Report
- September 2025
- 250 Pages
Global
From €3985EUR$4,490USD£3,461GBP
- Report
- September 2025
- 250 Pages
Global
From €3985EUR$4,490USD£3,461GBP
- Report
- July 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,461GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,461GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,461GBP
- Report
- September 2025
- 185 Pages
Global
From €3994EUR$4,500USD£3,469GBP
- Report
- May 2025
- 183 Pages
Global
From €3994EUR$4,500USD£3,469GBP
- Report
- September 2025
- 150 Pages
Global
From €3417EUR$3,850USD£2,968GBP
- Report
- August 2025
- 150 Pages
Global
From €3417EUR$3,850USD£2,968GBP
- Report
- September 2025
- 150 Pages
Global
From €3950EUR$4,450USD£3,430GBP
- Report
- June 2025
- 150 Pages
Global
From €2396EUR$2,699USD£2,080GBP
- Report
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Report
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,150GBP
- Report
- June 2025
- 400 Pages
Global
From €4393EUR$4,949USD£3,815GBP

Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases.
In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more